Direct celltocell spread of human immunodeficiency virus type 1 (HIV1) between T cells at the virological synapse (VS) is an efficient mechanism of viral dissemination. Tetherin (BST2/CD317) is an interferoninduced, antiretroviral restriction factor that inhibits nascent cellfree particle release. The HIV 1 Vpu protein antagonizes tetherin activity; however, whether tetherin also restricts cellcell spread is unclear. We performed quantitative celltocell transfer analysis of wildtype (WT) or Vpudefective HIV 1 in Jurkat and primary CD4 T cells, both of which express endogenous levels of tetherin. We found that Vpudefective HIV1 appeared to disseminate more efficiently by celltocell contact between Jurkat cells under conditions where tetherin restricted cellfree virion release. In T cells infected with Vpu defective HIV1, tetherin was enriched at the VS, and VS formation was increased compared to the WT, correlating with an accumulation of virus envelope proteins on the cell surface. Increasing tetherin expression with type I interferon had only minor effects on celltocell transmission. Furthermore, small interfering RNA (siRNA)mediated depletion of tetherin decreased VS formation and celltocell transmission of both Vpudefective and WT HIV1. Taken together, these data demonstrate that tetherin does not restrict VSmediated T celltoT cell transfer of Vpudefective HIV1 and suggest that under some circumstances tetherin might promote celltocell transfer, either by mediating the accumulation of virions on the cell surface or by regulating integrity of the VS. If so, inhibition of tetherin activity by Vpu may balance requirements for efficient cellfree virion production and celltocell transfer of HIV1 in the face of antiviral immune responses.
Cells have evolved a number of barriers to resist invading microorganisms. One mechanism that appears to be particularly important in counteracting HIV1 infection is a group of interferoninducible, innate restriction factors that includes TRIM5α, APOBEC3G, and tetherin (38, 49, 69, 79) . Tetherin (BST 2/CD317) is a host protein expressed by many cell types, including CD4 T cells, that acts at a late stage of the HIV1 life cycle to trap (or "tether") mature virions at the plasma membranes of virusproducing cells, thereby inhibiting cellfree virus release (49, 56, 81) . This antiviral activity of tetherin is not restricted to HIV1, and tetherin can also inhibit the release of other enveloped viruses from infected cells (31, 40, 54, 62) . What the cellular function of tetherin is besides its antiviral activity is unclear, but because expression is upregulated following alpha/beta interferon (IFNα/β) treatment (1) and tetherin can restrict a range of enveloped viruses, tetherin has been postulated to be a broadacting mediator of the innate immune defense against enveloped viruses.
To circumvent restriction of particle release, HIV1 encodes the 16kDa accessory protein Vpu, which antagonizes tetherin and restores normal virus budding (47, 78) . The molecular mechanisms by which Vpu does this are not entirely clear, but evidence suggests that Vpu may exert its antagonistic function by downregulating tetherin from the cell surface, trapping it in the transGolgi network (10) and targeting it for degradation by the proteasome (12, 39, 81) or lysosome (9, 25, 44) ; however, degradation of tetherin may be dispensable for Vpu activity (13) , and in HIV1infected T cells, surface downregulation of tetherin has been reported to be minor (45) , suggesting that global removal of tetherin from the plasma membrane may not be necessary to antagonize its function.
Tetherinmediated restriction of HIV1 and antagonism by Vpu have been the focus of much research, and inhibition of cellfree virus infection has been well documented (33, 4749, 77, 81, 82) . In contrast, less studied is the impact of tetherin on direct cellcell dissemination. For example, it is not clear if tetherinmediated restriction inhibits T cellT cell spread as efficiently as cellfree release or whether tetherin affects VS formation. To address these questions, we analyzed Vpu and Vpu viruses for their ability to spread directly between Jurkat T cells and primary CD4 T cells in the presence or absence of endogenous tetherin. Our data suggest that tetherin does not restrict HIV1 in the context of celltocell transmission of virus between T cells expressing endogenous tetherin. Interestingly, we also that observed that Vpudefective virus may disseminate more efficiently by cellcell spread at the VS. We postulate that cellcell spread may favor viral pathogenesis by allowing HIV1 to disseminate in the presence of tetherin during an interferonproducing innate response.
MATERIALS AND METHODS
The CD4 /CXCR4 T cell line Jurkat CE6.1 (from the American Type Culture Collection [ATCC]) was maintained in suspension cell growth medium (GM), consisting of RPMI 1640 (Gibco, BRL) supplemented with streptomycin (100 μg/ml), penicillin (100 U/ml), and 10% fetal calf serum (FCS). The HIV1 clone pNL4.3 and the Vpudeleted derivative pNL4.3ΔVpu were generously provided by Klaus Strebel (NIAID, NIH) (33) . Infectious virus was generated by transfecting plasmids into 293T cells using Fugene 6 (Promega), and virus was harvested after 48 h, quantified by p24 enzymelinked immunosorbent assay (ELISA) and infectivity assay, and used to infect T cells. To prepare cells infected with HIV1 wildtype (WT) pNL4.3 or pNL4.3ΔVpu (termed JurkatpNL4.3 WT or JurkatΔVpu), 1 × 10 Jurkat cells were infected at an MOI of 0.005 and incubated for 7 to 10 days. Cells were phenotyped for surface Env expression using monoclonal Jurkat T cells were infected with pNL4.3 WT or ΔVpu virus, and the percentage of infected cells was quantified by intracellular Gag staining at 2, 4, and 7 days postinfection. Briefly, cells were fixed in 4% formaldehyde, washed, and permeabilized in BD Perm/Wash buffer (BD Biosciences), and HIV1 Gag was detected with the PEconjugated antibody RC57RD1 (Coulter) and data acquired using either a FACSCalibur and CellQuest 5.0 or an LSRII (BD Biosciences) with FACSDiva software. Cellfree supernatants were also collected from HIV1infected T cells, and Gag p24 levels were quantified by ELISA as described previously (29) . Viral infectivity was measured on HeLa Tzmbl reporter cells (donated by J. Kappes, X. Wu, and Tranzyme Inc. and obtained from the Center for AIDS Reagents, National Institutes of Biological Standard and Control, United Kingdom) using the BrightGlo luciferase assay kit (Promega). Viral infectivity was either expressed as 50% tissue culture infective doses (TCID )/ml or normalized to Gag p24 to calculate the TCID /ng p24.
A total of 5 × 10 JurkatpNL4.3 WT or JurkatΔVpu cells were washed in WB and incubated on polyLlysine (Sigma)treated coverslips at 37°C for up to 60 min. Cells were then fixed in 4% formaldehyde (FA) in phosphatebuffered saline (PBS)1% BSA for 15 min at 4°C, followed by quenching in 50 mM ammonium chloride for 10 min at room temperature (RT). For VS experiments, JurkatpNL4.3 or JurkatpNL4.3ΔVpu cells were mixed with an equal number of primary CD4 target T cells, and conjugates were allowed to evolve by incubation on polyLlysine treated coverslips for 60 min at 37°C in the presence of the nonblocking MAbs specific for Env (MAb 5069, donated by S. ZollerPazner and obtained from the Center for AIDS Reagents, National Institutes of Biological Standard and Control, United Kingdom) and CD4 (MAb L120.3, donated by D. Buck and obtained from the Center for AIDS Reagents, National Institutes of Biological Standard and Control, United Kingdom) as described previously (27) . In some cases a tetherinspecific MAb (Abnova) was included to label surface tetherin at the VS. Alternatively, infected primary CD4 T cells were used as donor cells and mixed with target cells prelabeled with the CD4 MAb L120. Conjugate evolution was arrested by fixation with cold 4% FA, and the cells were permeabilized in 0.1% Triton X1005% FCS for 20 min at RT and washed extensively in PBS. Gag was stained with rabbit antisera against HIV Gag p17 and p24 (donated by G. Reid and obtained from the Center for AIDS Reagents, National Institutes of Biological Standard and Control, United Kingdom) and Vpu with rabbit antiVpu (donated by K. Strebel and obtained from the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH) (37) . Primary antibodies were detected with fluorescein isothiocyanate (FITC), tetramethyl rhodamine isocyanate (TRITC), or Cy5conjugated donkey antimouse, human, or rabbit secondary antibodies that were tested for an absence of interspecies reactivity (Jackson Immunoresearch) or with Alexaconjugated isotype specific antiIgG1, IgG2a, or IgG2b (Invitrogen). Coverslips were mounted with ProLong antifade mounting solution (Molecular Probes), and laser scanning confocal microscopy (LSCM) was performed using a Leica SP2 or SPE laser scanning confocal microscope. Image processing was performed using MetaMorph version 7.1 and Adobe Photoshop version CS2. JurkatpNL4.3 WT or JurkatΔVpu cells in conjugates with target cells were prepared and analyzed as described above, and multiple random sections of lowpower fields were acquired. The total number of effector cells was counted and the percentage of effectors within conjugates quantified. Conjugates were defined as closely apposed pairs of cells containing one CD4 primary cell and one Env or Gag infected cell. Polysynapses were defined as a single effector cell engaged with multiple target cells. Each conjugate was analyzed for polarization to the cellcell interface of CD4, Env and Gag, or Vpu and tetherin. Statistical analysis was performed using a nonparametric MannWhitney test or analysis of variance (ANOVA) with Bonferroni correction for multiple comparisons. Statistical significance was assumed when the P value was <0.05.
A total of 5 × 10 JurkatpNL4.3 WT or JurkatΔVpu cells were mixed with an equal number of uninfected T cells and incubated for up to 6 h. At 0, 1, 3, and 6 h postmixing, cells were lysed, genomic DNA was extracted (Qiagen), and quantitative realtime PCR was performed using an ABI 7000 to measure cell cell spread of HIV1 (29) . Alternatively, pNL4.3 WT or ΔVpuinfected primary T cells were mixed with uninfected T cells for 0, 3, 6, or 12 h and analyzed by realtime PCR. In some cases, target cells were pretreated with 10 μM zidovudine (obtained from the NIH AIDS Research and Reference Reagent Program) for an hour at 37°C to achieve a final concentration of 5 μM after donor and target cells were mixed. To measure cellcell spread by flow cytometry, an adaptation of the assay of Sourisseau et al. (74) was used. Briefly, an equal number of HIV1infected donor cells were mixed with carboxyfluorescein succinimidyl ester (CFSE) or CellTrace Far Redlabeled target T cells (2 μM; Invitrogen) and incubated for 0, 6, and 24 h at 37°C. In some cases, target cells were pretreated with 10 μM zidovudine as described above. Cells were then fixed in 4% formaldehyde, washed, and permeabilized in BD Perm/Wash buffer (BD Biosciences), and HIV1 Gag was detected with the PEconjugated antibody RC57RD1 (Coulter) and data acquired using either a FACSCalibur and CellQuest 5.0 or an LSRII (BD Biosciences) with FACSDiva software. Flow cytometry acquisition for gating on single cells was performed on the LSRII using doublet discrimination. The percentage of Gag CFSE or CellTrace FarRed labeled target cells was quantified and data analysis performed using CellQuest 5.0 or FlowJo.
JurkatpNL4.3 WT, JurkatpNL4.3ΔVpu, or infected primary CD4 T cells were treated with 500 U/ml of IFNβ (a kind gift from M. Noursadeghi, UCL) for 24 h prior to being mixed with target cells and analyzed by LSCM and realtime PCR. Uninfected Jurkat T cells and primary CD4 T cells were similarly treated with IFNβ; surface stained for tetherin, LFA1 (MAb L130; BD Biosciences), and ICAM1 (MAb LB2; BD Biosciences); and analyzed by flow cytometry.
At total of 1 × 10 Jurkat T cells or primary CD4 T cells were nucleofected (Amaxa) with either small interfering RNA (siRNA) oligonucleotides targeting tetherin or control sequences (Dharmacon Smartpool catalogue numbers L011817 and D 0012100120, respectively), and 24 h later cells were infected with pNL4.3 WT or pNL4.3ΔVpu virus at an MOI of 0.05. After 72 h, the infected cells were mixed with uninfected T cells, cellcell spread was measured by realtime PCR, and VS formation was quantified. Knockdown of tetherin expression was confirmed by surface staining and flow cytometric analysis. JurkatpNL4.3 WT or JurkatpNL4.3ΔVpu cells were pelleted by centrifugation, and cells were washed twice in cold PBS. Cell pellets were lysed (radioimmunoprecipitation assay [RIPA] buffer, consisting of 50 mM TrisHCl [pH 8], 150 mM NaCl, 1% NP40, 0.1% SDS, 0.5% deoxycholic acid, 1 mM phenylmethylsulfonyl fluoride [PMSF], and Complete protease inhibitor Cocktail [Roche, United Kingdom]) on ice for 10 min, and soluble protein collected following centrifugation at 15,000 × g for 10 min at 4°C. Lysates were stored at −80°C, and the protein concentrations were determined using a bicinchoninic acid (BCA) protein assay reagent kit (Pierce). Virus was purified from cellfree supernatants by ultracentrifugation through a 25% sucrose cushion, and pelleted virus was resuspended in equal volumes of PBS and stored at −80°C. Twenty micrograms of cell lysate and an equal volume of purified virus were separated by SDSPAGE. Proteins were transferred onto nitrocellulose, blocked in PBS with 0.5% Tween 20 and 5% skim milk (Marvel), probed with rabbit antiserum raised against HIV1 Gag (donated by G. Reid and obtained from the CFAR) or actin (Sigma) followed by goat antirabbithorseradish peroxidase (HRP) (Dako), and visualized by enhanced chemiluminescence (ECL) (Amersham). Vpudeficient HIV1 disseminates efficiently between CD4 T cells.
Go to:
Jurkat T cells were infected with pNL4.3 or JurkatpNL4.3ΔVpu and cultured for 10 days before being prepared for transmission electron microscopy (TEM) as described previously (27) . Briefly, the cells were pelleted by centrifugation, fixed in 0.5% glutaraldehyde, and postfixed in 1% osmium tetrozide and 1.5% potassium ferricyanide for 1 h. After extensive washing in water, the cells were incubated in 0.5% magnesium uranyl acetate, dehydrated, and embedded in Epon resin. Ultrathin sections were cut, collected on TEM grids, and stained with lead citrate. Sections were analyzed using a Philips FEI Technai 12 transmission electron microscope, and digital images were captured using Soft Imaging software and processed using Abode Photoshop.
RESULTS
In order to investigate the effect of Vpu on cellcell spread of HIV1, 293T cells were transfected with plasmids encoding either fulllength pNL4.3 wildtype virus or pNL4.3 with a defective Vpu gene (ΔVpu) to generate infectious HIV1 pNL4.3 WT and pNL4.3ΔVpu virus (33, 77) . To confirm that these viruses displayed the appropriate Vpudependent cellfree budding defect, Jurkat T cells were infected with HIV1 pNL4.3 WT or pNL4.3ΔVpu, and cellfree virus release from T cells was examined by Western blotting at 72 h postinfection ( Fig. 1A ) and infected cells visualized by electron microscopy (Fig. 1B ). In agreement with previous reports, T cells infected with the Vpudefective virus pNL4.3ΔVpu released less Gag p24 than those infected with pNL4.3 WT, with a concomitant increase in cellassociated p24 ( Fig. 1A) (33, 47, 49, 81) . Electron microscopy imaging confirmed that nascent pNL4.3ΔVpu virions were retained at the plasma membrane by characteristic membrane tethers ( Fig. 1B) (49) .
FIG. 1.
Confirmation of the Vpumediated budding defect in Jurkat T cells. (A) Jurkat T cells were infected with pNL4.3ΔVpu or pNL4.3 WT virus, and at 3 days postinfection the cells were pelleted and virus containing supernatants were harvested and purified ...
To examine cellcell spread of HIV1 between T cells in the presence and absence of Vpu (and, by extension, antagonized and unantagonized tetherin), Jurkat T cells were infected with either pNL4.3 WT or pNL4.3ΔVpu at a low MOI of 0.005 to favor cellcell spread, and at various time points thereafter virus release was quantified by infectivity assay and infected cells enumerated by intracellular Gag staining and flow cytometry (Fig. 1C ). As expected, more infectious virus was present in supernatants harvested from cells infected with pNL4.3 WT virus than in those from cells infected with pNL4.3ΔVpu at 2 days postinfection ( Fig. 1C) , when there were equivalent numbers of Gag cells, likely reflecting more efficient cellfree particle release, in agreement with Fig. 1A . Interestingly, this effect was not apparent at later time points (days 4, 7, and 10 postinfection [P > 0.05]) and appeared to correlate with an increase in the percentage of Gag T cells in the ΔVpuinfected cultures compared to WTinfected cultures. Notably, pNL4.3 WT and pNL4.3ΔVpu viruses produced by infected Jurkat cells showed the same relative infectivity when normalized to Gag p24 ( Fig. 1D) , demonstrating that the difference in replication kinetics is not due to pNL4.3ΔVpu virus being inherently more infectious than WT virus and suggesting that Vpudefective HIV1 may disseminate efficiently by direct T cellT cell transmission.
To rule out that doublets or aggregates between infected and uninfected cells may be artificially increasing the detection of Gag cells, additional experiments were performed on Jurkat cells infected with pNL4.3 WT or pNL4.3ΔVpu, in which we gated on the total live cell population and additionally gated out only the single cells using doublet discrimination. Figure 1E shows that most of the cells in the infected cell population were indeed single cells, with relatively few cells apparent outside the single cell gate and no clear doublet population (which would appear as a distinct population below the single cells). There was no difference in intracellular Gag staining between the total cell population and the singlecell group, demonstrating that doublets or aggregates between infected and uninfected cells are infrequent and do not artificially increase our detection of Gag infected cells. In addition, infected cells were treated with trypsinEDTA prior to fixing to further diminish doublet formation and to remove surface absorbed p24. There was no difference in the intracellular Gag staining between cells treated with Quantification of VS formation by WT and Vpudefective HIV1.
Tetherin, but not Vpu, is a component of the VS.
trypsinEDTA and those left untreated ( Fig. 1E ), providing further evidence that doublets are infrequent and indicating that most of the Gag p24 that we are detecting by flow cytometry is likely to be intracellular.
Cellcell spread of HIV1 takes place at virological synapses. To investigate the effect of Vpu and tetherin on VS formation, Jurkat T cells were infected with either pNL4.3 WT (termed JurkatpNL4.3 WT cells) or pNL4.3ΔVpu (Jurkat ΔVpu cells), mixed with primary CD4 target T cells, and examined for virological synapse (VS) formation by immunofluorescence labeling (IF) and laser scanning confocal microscopy (LSCM) ( Fig.  2A ). The T cell VS is characterized by coenrichment of HIV1 Env and Gag on the infected cell and of CD4 on the target cell at sites of cellcell contact (27) . Quantification of conjugate and VS formation revealed that JurkatΔVpu cells were not impaired in VS formation but, interestingly, formed significantly more synapses than JurkatpNL4.3 WT cells (46% and 22%, respectively; P = 0.03), and this was not due to enhanced conjugate formation (37% and 45%, respectively; P = 0.2) ( Fig. 2B ). In addition, VSs that formed between JurkatΔVpu cells and target T cells were morphologically similar to those for JurkatpNL4.3 WT cells in recruitment of CD4, Env, and Gag ( Fig. 2A) . Moreover, we also detected more polysynapses forming between target T cells and JurkatΔVpu cells (defined as a single HIV1 infected cell interacting with >1 target cell with clustering of HIV1 at multiple sites of cellcell contact [61] ) than with JurkatpNL4.3 WT cells (48% and 26%, respectively; P = 0.02) ( Fig. 2C ).
FIG. 2.
ΔVpu virus induces VS formation more efficiently than WT Vpu expressing virus. (A) HIV1infected cells were mixed with uninfected primary target T cells (asterisks) in the presence of nonblocking MAbs against Env (blue) and CD4 (green) and incubated ...
To address the apparent increase in VS formation in the absence of Vpu, flow cytometry was performed to measure HIV1 Env surface expression. These analyses revealed that JurkatΔVpu cells express up to 3fold more envelope glycoprotein at the cell surface than JurkatpNL4.3 WT cells (P = 0.008) ( Fig. 2D ). Because unantagonized tetherin physically retains Envexpressing virions at the cell surface, this result is not entirely unexpected; however, since Envreceptor interactions are known to drive VS formation (27) , increased exposure of Env at the plasma membrane may contribute to the increased frequency of VS formation by Vpudefective HIV1.
Next we investigated whether tetherin was present at sites of cellcell contact. To do this, conjugates between JurkatΔVpu and target T cells were allowed to form in the presence of monoclonal antibody to label cell surface tetherin and then fixed, stained, and analyzed by confocal microscopy. We detected copolarization of tetherin with Env on infected T cells at sites of cellcell contact in the majority of VSs examined (65% n = 64) (Fig. 3A) , and tetherin also localized at multiple sites of cellcell contact seen during polysynapse formation (Fig. 3B ). Strong enrichment of tetherin at the VS was often associated with strong Env polarization (data not shown). Moreover, tetherin could sometimes be visualized on the target T cell at the cellcell interface, possibly due to incorporation into transmitted virions attached to the target cell membrane (56) . Tetherin also colocalized with Env on the surface of unconjugated HIV1infected T cells (Fig. 3C ) that were not engaged in a VS (75% ± 6% [mean ± standard error of the mean {SEM}]; n = 55), indicating that tetherin is a component of sites of HIV1 assembly and budding of cellfree virus. Collectively, these data show that tetherin is present in the VS but that it does not impair cellcell contact or VS formation. Quantification of cellcell spread by WT and Vpudefective HIV1.
To investigate whether Vpu was similarly enriched at the VS in JurkatpNL4.3 WT cells, conjugates were permeabilized and stained for Vpu. Intracellular Vpu was clearly visible in HIV1infected cells and was often localized to perinuclear regions, as described previously (33) . Unlike tetherin, Vpu was only infrequently associated with the VS (14%; n = 26) and did not appear to be enriched at sites of cellcell contact (Fig. 3D) . Thus, recruitment of Vpu to the VS does not appear to be essential for VS formation and cellcell spread.
To directly compare the efficiencies of cellcell transfer in the presence and absence of Vpu and thus endogenous tetherin, we performed a flow cytometry assay to quantify the appearance of Gag target T cells following coculture with pNL4.3 WT or pNL4.3ΔVpuinfected T cells (74) . Dyelabeled target T cells were incubated with WT or ΔVpuinfected T cells at 7 to 10 days postinfection (both routinely were >80% infected [data not shown]) for 6 h and 24 h, fixed, permeabilized, and stained for intracellular Gag, and the number of Gag dyelabeled target cells was quantified by flow cytometry (Fig. 4A ). Gag transfer from both WT and ΔVpuinfected cells to dyelabeled target cells was detected within 6 h of coculture, increasing approximately 3fold by 24 h. This is a time frame in which dissemination of virus is by direct cellcell rather cellfree transfer due to faster transmission kinetics of cellcell dissemination (6, 8, 29, 41, 74) . Figure 4A shows that both WT and ΔVpu viruses were capable of disseminating between T cells, as evidenced by the appearance of the Gag dyelabeled population, and that cellcell transfer of Vpu defective HIV1 from tetherinexpressing T cells was not impaired compared to that of WT virus. In fact, cellcell transfer of ΔVpu virus appeared to be somewhat more efficient than that of WT virus at both 6 h (12.5% and 3.1%, respectively; P < 0.001) and 24 h (36.7% and 14%, respectively; P < 0.001). To check that the appearance of Gag target cells was not a result of formation of doublets between infected and uninfected cells rather than bone fide acquisition of Gag through virus transfer, we repeated the experiment and performed additional analysis to exclude doublets by gating out single cells from the total live cell population, an example of which is shown in Fig. 4B . We found little difference in the number of Gag target cells detected when applying either gating strategy, confirming that this assay is appropriately detecting cellcell transfer of both WT and ΔVpu viruses. The lack of a detectable population of doublets is in agreement with estimates that the average life span of the T cell VS is roughly 1 h, after which >90% of conjugates separate (41) . In addition, treating cells with trypsinEDTA after coincubation but prior to fixing had no effect on the proportion of Gag target cells detected after 6 h (data not shown), in agreement with Fig. 1E , suggesting that most of the Gag staining that we detected is intracellular. To investigate whether the intracellular Gag that we detected in target T cells is due to the synthesis of new Gag protein as a result of productive infection, target T cells were either left untreated or treated with the reverse transcriptase inhibitor zidovudine prior to being mixed with donor cells (Fig. 4C ). Inhibition of reverse transcription had no effect on the mean fluorescence intensity (MFI) of Gag staining in the newly infected Gag target cell population after only 6 h of coculture, as expected, because within this short time period we will be detecting mostly transfer of viral material rather than new Gag synthesis. In contrast, after 24 h of incubation, target cells treated with zidovudine showed a partial reduction in the MFI of Gag staining following coculture with WT or ΔVpuinfected cells, demonstrating that some of the Gag signal detected in newly infected target cells does indeed result from de novo synthesis as a result of productive infection. The accumulation of Gag in both zidovudinetreated and untreated target cells after 24 h likely represents the continual and nonreversible transfer of virus during coculture.
To follow cellcell transfer using a different assay system we used a quantitative realtime PCR assay that measures de novo synthesis of HIV1 pol DNA transcripts as a marker of new virus infection (29, 41) . This assay detects late HIV1 reverse transcripts that are relevant to postentry infection events and proximal to integration and productive infection, and treating target T cells with zidovudine appropriately reduces the detection of RT products (Fig. 4D ). JurkatpNL4.3 WT and JurkatΔVpuinfected cells were mixed with target T cells and incubated for 1, 3, and 6 h at 37°C, and realtime PCR was performed (Fig.  4D ). This is a time frame that allows detection of pol reverse transcript products arising from efficient cellcell spread but not cellfree infection (29, 41, 74) . In support of the results obtained when quantifying cellcell spread by flow cytometry, Fig. 4D reveals that after 6 h of coculture between pNL4.3Vpu infected cells and target cells, a 6fold increase in the appearance of reverse transcripts over the baseline level (t = 0 h) was detected, indicative of cellcell spread. In contrast, WT virus appeared to be less efficient and displayed a more modest 1.2fold increase (P < 0.05), again suggesting more rapid dissemination of Vpudefective HIV1.
Interferon treatment of T cells upregulates tetherin expression and inhibits virus release in the absence of Vpu (48, 49) . To examine the effect of tetherin upregulation in the context of cellcell spread at the VS, JurkatpNL4.3 WT and JurkatΔVpu cells were pretreated with IFNβ for 24 h, washed, and assayed for cellcell spread by flow cytometry and realtime PCR (Fig. 4A and D) . Notably, although the release of nascent cellfree virus was impaired after IFN treatment ( Fig. 4E ) and tetherin surface expression was upregulated (Fig. 4F) , confirming appropriate activity of this cytokine, IFN treatment and the resulting tetherin upregulation did not inhibit cellcell spread of either WT or ΔVpu virus ( Fig. 4A and D) . When assayed by both realtime PCR and flow cytometry, JurkatpNL4.3 WT cells treated with IFN showed a slight, 2fold increase in HIV1 transmission, but this did not reach statistical significance. Similarly, IFN treatment did not inhibit cellcell interactions or VS formation but rather increased the frequency of VS formation by JurkatpNL4.3 WT cells 2.3fold (P < 0.05) (Fig. 4G) , correlating with the observed slight increase in cellcell spread. VS formation by ΔVpu virus was similarly uninhibited by IFN treatment compared to cells that were not exposed to IFN, indicating that tetherin does not inhibit VS formation and that upregulating tetherin expression on the cells that already express tetherin to relatively high levels does not affect cellcell spread in this assay system. We also confirmed that while IFN treatment increased the surface expression of tetherin on Jurkat T cells and primary T cells, there was no effect on surface expression of the adhesion molecules LFA1 and ICAM1, which also contribute to cellcell spread at the VS (Fig. 4F) (28) . Taken together, these data indicate that upregulating endogenous tetherin on T cells does not prevent productive T cellT cell spread of HIV1.
If cellcell spread of HIV1 is restricted by tetherin, it would be expected that siRNA knockdown of endogenous tetherin might increase transmission of Vpudefective HIV1. Conversely, if tetherin does not inhibit HIV1 dissemination at the VS, then siRNA knockdown might be expected to have little effect on transmission. To differentiate between these two possibilities, Jurkat T cells were nucleofected with siRNA targeting tetherin and infected with pNL4.3ΔVpu or WT virus, and cellcell spread was measured at 72 h postinfection by realtime PCR. Flow cytometry confirmed that antitetherin siRNA reduced plasma membrane expression by an average of 50 to 70% (Fig. 5A) . Moreover, cells treated with either anti tetherin or control siRNA were susceptible to infection by HIV1 (data not shown). Analysis of direct cellcell spread of HIV1 by realtime PCR showed that siRNA knockdown of tetherin did not increase cellcell transmission of pNL4.3ΔVpu or WT virus compared to cells treated with control siRNA (Fig.  5B) . In contrast, we observed that tetherin knockdown decreased cellcell spread of both WT and pNL4.3ΔVpu virus by up to 55%. To investigate this further, Jurkat T cells were treated with control or tetherin siRNA and infected with WT or ΔVpu virus, and conjugate and VS formation was quantified (Fig. 5C ). Knockdown of tetherin in effector T cells had a little effect on conjugate formation but significantly reduced VS formation by ΔVpuinfected cells, by approximately 45% compared to cells treated with control siRNA (P < 0.01). Similarly, a 50% reduction in WT VS formation was also observed, but this did not reach statistical significance (P > 0.05). It should be noted that VSs could sometimes be observed without detectable tetherin enrichment at sites of cellcell contact following RNAi (Fig. 5D) , with the caveat that tetherin localization at the VS following knockdown may be below the level of detection by immunofluorescence microscopy. Thus, rather than inhibiting transmission, tetherin may partially contribute to the HIV1 VS. Cellcell spread of HIV1 from primary CD4 T cells.
or siRNA targeting tetherin (black line), and 48 h later surface tetherin expression
Because tetherin knockdown with RNAi appeared to reduce cellcell spread of WT HIV1 that antagonizes tetherin, we wished to examine to what extent antagonized tetherin was downregulated from the surface of T cells infected with HIV1 in the absence of RNAi. Infected T cells were stained for surface tetherin and intracellular Gag, and the relative proportions of tetherinexpressing infected and uninfected cells were quantified by flow cytometry (Fig. 5E ). As expected, surface expression of tetherin was unchanged on ΔVpuinfected cells compared to uninfected control cells (90% tetherin positive [MFI = 24] compared to 86% tetherin positive [MFI = 22]) at 72 h postinfection, the time point at which infected cells were used to assay cellcell spread following RNAi. In contrast, while the majority of WT Gag cells still expressed tetherin at 72 h (73%; MFI = 21) a minor but distinct Gag tetherin population was apparent (27%; MFI = 4.6), which expanded to 57% by 120 h postinfection (MFI = 4.4). The fact that most of our WTinfected cells still expressed some tetherin at the plasma membrane at 72 h postinfection may explain in part why we could detect an effect of RNAi knockdown of tetherin on cell cell spread of WT virus.
Although the Jurkat T cell line is a useful model for studying HIV1 infection in vitro, primary CD4 T cells are the natural targets for HIV1 in vivo. To address whether primary T cells are similarly affected by Vpu and tetherin expression, CD4 T cells were isolated from healthy donors and infected with either pNL4.3 WT or pNL4.3ΔVpu, and cell cell spread was quantified by realtime PCR (Fig. 6A) . In order to directly compare cells infected with Vpuexpressing and nonexpressing HIV1 from multiple donors, we used an immortalized T cell line as uninfected targets to remove any contribution from polymorphisms that may affect HIV1 entry and reverse transcription, since this has been shown to be a suitable substitute in this assay (41) . In agreement with our previous results, ΔVpu virus could be transmitted by cellcell spread in the presence of tetherin, and this was not inhibited by IFN treatment and tetherin upregulation. Again, there was a modest but significant increase in cellcell spread by ΔVpu virus compared to WT virus at both 6 h (1.7 compared to 1fold increase over baseline; P = 0.01) and 12 h (2.1 compared to 1.2fold increase over baseline; P = 0.005), and cellcell spread of WT was also somewhat more efficient following IFN treatment (P = 0.04), but this was not seen with ΔVpu virus (P = 0.2). Moreover, siRNA knockdown of endogenous tetherin in primary CD4 T cells reduced surface expression by approximately 30% (Fig. 6B ) but did not increase cellcell spread, and in good correlation with results obtained with Jurkat T cells, siRNA knockdown of tetherin reduced cellcell spread by 56% (Fig. 6C ). Finally, tetherin could also be detected at the VS on HIV1infected primary CD4 T cells colocalizing with Env at sites of cellcell contact (Fig.  6D ).
FIG. 6. Cellcell spread of HIV1 from infected primary CD4 T cells. (A)
Primary CD4 T cells infected with pNL4.3 WT (white bars) or ΔVpu (black bars) were either left untreated or pretreated with 500 U/ml interferon for 24 h before ...
DISCUSSION
Cellular restriction factors target HIV1 at different stages of the viral life cycle to inhibit or limit virus replication, often in response to IFN induction (46) . HIV1 has evolved a number of mechanisms to counteract restriction factors, including expression of the accessory proteins Vif (which inhibits APOBEC3mediated cytidine deamination of viral transcripts) (69) and Vpu (which overcomes tetherin mediated inhibition of HIV1 release) (49, 81) . During HIV1 cellcell spread, viral assembly and egress are polarized toward the target cell (7, 22, 27, 55) , and so we hypothesized that cellcell spread of HIV1 between T cells may be able to overcome restriction by temporally and spatially saturating inhibitory Conversely, evidence suggests that cellcell spread of HIV1 occurs by budding of virions from the plasma membrane of infected cells into the synaptic cleft (22, 27) ; thus, aspects of particle release and attachment and entry into target cells are mechanistically analogous to cellfree infection. For this reason it is also possible that restriction factors may be equally active against direct cellcell transfer. With this in mind, we investigated whether cellcell spread of HIV1 can overcome restriction by the most recently described restriction factor, tetherin, and by extension whether Vpu is necessary for transmission at the VS. Our data using Vpudefective virus, interferoninduced tetherin upregulation, and RNAi suggest that unantagonized tetherin is present at the T cell VS but that it does not significantly inhibit cellcell interactions or VS formation. Despite efficient VS formation by Vpudefective HIV1, because tetherin physically links virions to the plasma membrane (49, 56) , it remained possible that infection of target cells could be inhibited due to restriction of infectious particle release at sites of cellcell contact even in the presence of efficient VS formation. Our data suggest that this is not case for the following reasons: first, we could detect transfer of HIV1 Gag to target cells by flow cytometry, the production of newly synthesized reverse transcripts by quantitative realtime PCR, and the synthesis of new viral Gag protein when T cells infected with ΔVpu virus were mixed with uninfected T cells, thus demonstrating that HIV 1 can be productively transmitted to target cells across the VS in the presence of endogenous tetherin; second, IFN treatment of infected T cells did not inhibit Gag transfer or the synthesis of HIV1 reverse transcripts, indicating that HIV1 can be efficiently transmitted even after tetherin upregulation by IFN; third, siRNA knockdown of tetherin did not increase transmission of HIV1 at the T cell VS; and fourth, tethered viruses are fully infectious and thus tetherin does not appear to inhibit viruscell fusion as a consequence of virion incorporation. Taking our findings together, we conclude that HIV1 can disseminate by direct T cellT cell transfer in the presence of endogenous tetherin expressed on the virus producing T cell. In the same cellular system, tetherin restricts the release of cellfree virus particles. It has previously been reported that cellcell spread of HIV1 is less sensitive than cellfree infection to TRIM5α restriction (58) , and so in addition to promoting more rapid infection kinetics, another advantage of cell cell spread may be to allow HIV1 to disseminate in the presence of host restriction factors.
Tetherin is polarized on epithelial cells, where it modulates actin dynamics and provides a link between the actin network and lipid rafts (60) . Tetherin binding to the BARRacGAP protein RICH2 appears to be essential for subapical Factin organization, and perturbation of this interaction increases Rac activation and causes loss of apical microvilli (60) . Tetherin is also reported to be present in lipid rafts (34) , which are sites of HIV1 assembly at the plasma membrane (4, 50, 51) , and maintenance of the integrity of lipid rafts and the actin cytoskeleton are required for efficient HIV1 dissemination at the VS (29, 30, 55) . Rather than increasing HIV1 dissemination, we found that depleting surface tetherin by nucleofecting T cells with siRNA reduced VS formation and cellcell spread of HIV1, in keeping with the idea that tetherin may play a more general role in T cells via interacting with the actin cytoskeleton and plasma membrane microdomains. If tetherin does indeed modulate cytoskeletal dynamics and plasma membrane organization, this raises the question of how WT strains of HIV1 spread by cellcell transmission in the face of Vpu expression (6, 22, 27, 64, 74) . Mutants of Vpu that lack the phosphoserine acceptors that mediate binding to βTrCP1/2 maintain tetherin antagonism in T cells but fail to remove it from the plasma membrane and degrade it (13) , suggesting that Vpu may antagonize tetherin by excluding it from sites of virus assembly. Indeed, it has been proposed that tetherin degradation may not be necessary for Vpu antagonism of its effects on virus release, and in some systems degradation appears to be quite inefficient (10) . We found that siRNA knockdown of tetherin impaired WT HIV1 dissemination by cellcell spread, indicating that loss of tetherin from the plasma membrane may negatively affect T cell function, at least in the context of HIV1 transmission. We also detected a decrease in surface tetherin expression on cells infected with WT virus but not Vpudefective HIV1, and thus we cannot exclude the possibility of temporal, as well as spatial, effects of tetherin antagonism in our system. Future work to elucidate the normal cellular function of tetherin/BST2 and antagonism by Vpu will undoubtedly shed light on the role of tetherin in cellcell interactions and HIV1 dissemination.
Interestingly, we observed that Vpudefective HIV1 appears to disseminate more efficiently by direct cellcell transfer, and we hypothesize that this is likely due, at least in part, to increased VS and polysynapse formation. In support of our observations, Gummurulu et al. have previously reported that more rapid cellcell spread of HIV1 occurs in culture following mutation in vpu (19) , while data from important early studies characterizing the phenotype of Vpudefective HIV1 also noted that Vpu defective virus was able to spread in culture (33, 68, 77, 80, 85) , hinting that Vpu may contribute to replication in vitro by mechanisms involving cellcell transfer. We hypothesize that by preventing the release of virions from the cell surface, unantagonized tetherin could trigger more Envdependent VS to evolve. In this model, mature infectious virions remaining associated with the producer cell could then be poised to engage and recruit CD4 and coreceptor on the target cell, contributing to more rapid virus transmission. The presence of preformed infectious virus accumulating at the cell surface could also increase replication kinetics by obviating any lag in recruiting viral proteins to sites of de novo virus assembly at the VS (22) . In support of this, PaisCorreia et al. have described the presence of extracellular viral assemblies (or biofilms) on the surface of HTLV1infected lymphocytes that mediate cellcell spread (53) . Notably, these biofilms contain tetherin, among other cellular proteins. HTLV1 disseminates exclusively by cellcell spread at virological synapses (24) and appears to be resistant to tetherinmediated restriction, but it does not encode a known tetherin antagonist, and it is tempting to speculate that HTLV1 may have adapted to exploit tetherin to enhance viral dissemination under certain conditions. Furthermore, directional spread of the related retrovirus murine leukemia virus (MLV) between fibroblasts is mediated in part by the transmission of surfaceassociated virions that are nonspecifically attached to the surface of the virusproducing cell via interactions with glycosaminoglycans (70) . MLV, like HTLV1, is not known to encode a tetherin antagonist (14); however, the effect of tetherin on directional cellcell spread of MLV is not clear at present. While we have hypothesized that tethered particles may contribute, at least in part, to transmission of Vpudefective HIV1, we cannot exclude the possibility that increased Env expression on ΔVpuinfected cells may be masking some restriction of virus spread; however, we did not observe any increase in HIV1 cellcell transmission when endogenous tetherin was depleted using siRNA, nor was spread restricted following tetherin upregulation with interferon, suggesting that tetherin does not prevent functional T cellT cell transfer.
While this paper was in preparation Casartelli et al. also reported that tetherin accumulates at sites of cell cell contact and does not prevent virological synapse formation (5) . In contrast to our results, it was reported that productive cellcell spread was sensitive to tetherinmediated restriction and that virions produced from cells expressing tetherin were transmitted by cellcell spread as large aggregates that had reduced infectivity (5) . While aspects of these two studies are in broad agreement, there are conflicting data; most notably, we found that cellcell spread of HIV1 between T cells is not restricted and that T cells can be productively infected with Vpudefective virus following cellcell spread. Moreover, we did not detect any loss of viral infectivity per se when virions were produced from T cells expressing endogenous tetherin. We believe that one possible explanation for the differences between that study and ours could be cell typedependent variation in the levels of tetherin expression, since the experimental approaches are broadly similar. Here we have used Jurkat T cells and primary T cells expressing endogenous tetherin. T cells express comparatively less tetherin than HeLa cells or 293T cells transfected with a recombinant plasmid (45, 48, 49, 81) , and it is possible that under conditions of high tetherin expression HIV1 cellcell spread may be impaired, whereas at lower levels tetherin may not restrict, or may even contribute to, cellcell spread. Contrasting results were also obtained in the two studies when T cells were used, and this too could be attributed to variation in tetherin expression between the different T cell lines and clones, a phenotype that Miyagi et al. have previously reported (45) . Moreover, we cannot exclude differences in the infection kinetics in donor cell populations and in the molecular mechanisms of cellcell spread between different donor and target cell combinations (e.g., T cellT cell versus epithelial cellT cell) as contributing factors.
Since tetherin antagonism is a highly conserved attribute of primate immunodeficiency viruses, be it associated with the Vpu, Nef, or Env genes (20, 26, 36, 46, 86) , our data raise the possibility that for optimal hosttohost transmission and systemic spread, HIV1 requires a balance between cellcell spread and the production of cellfree virions. The Vpu open reading frame reading frame is maintained in transmitted founder viruses (63) , and recent evidence suggests that of the three known zoonotic transfers of the simian immunodeficiency virus SIVcpz (whose Nef proteins antagonize chimpanzee but not human tetherin), only those that became HIV1 group M acquired the ability to target human tetherin in their Vpu proteins (66) . HIV1 group M, unlike groups N and O, was able to become a human pandemic virus rather than a localized epidemic virus, suggesting that attributes such as Vpu function may have favored humantohuman transmission. Once infection is established in lymphoid tissues such as the gut https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976402/ 12/18
Go to: associated lymphoid tissue (GALT) (a major site of HIV1 replication) (3, 18, 43, 57, 67, 83) , cellcell transfer may be an important mode of HIV1 dissemination, and one might speculate that the Vpu antagonism of tetherin may be less important at this stage. Alternatively, tetherin may restrict cellcell spread in other cellular systems such as macrophages and dendritic cells, and cell typespecific effects of interferon treatment on retroviral infection have been reported (15) . The interferon inducible nature of restriction factors such as tetherin and TRIM5α (46) has raised the possibility of using interferonbased therapy to upregulate the natural antiviral activity of cells; however, cellcell spread of HIV1 is less sensitive than cellfree infection to TRIM5α restriction (58) , and our data additionally suggest that cell cell spread is not efficiently restricted by tetherin. It is also interesting to note that interferon is ineffective at limiting viral spread in in vitro culture due to cellcell spread (84). If cellcell spread of HIV1 can overcome restriction factors in vivo, even in part, then this might contribute to the failure of IFN treatment in reducing the viral load in HIV1positive patients (11, 21, 23, 32, 35, 52, 59, 72, 76) , suggesting that such an antiviral strategy may be more complicated than anticipated.
